Rathbones Group PLC Has $14.04 Million Position in Colgate-Palmolive Company $CL

Rathbones Group PLC lessened its position in Colgate-Palmolive Company (NYSE:CL) by 12.0% in the 3rd quarter, Holdings Channel reports. The firm owned 175,577 shares of the company’s stock after selling 23,939 shares during the period. Rathbones Group PLC’s holdings in Colgate-Palmolive were worth $14,036,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of CL. Vermillion & White Wealth Management Group LLC grew its holdings in shares of Colgate-Palmolive by 86.1% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after buying an additional 155 shares during the period. Copia Wealth Management bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at $29,000. Cloud Capital Management LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter worth $30,000. MTM Investment Management LLC bought a new position in Colgate-Palmolive during the second quarter worth about $39,000. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Colgate-Palmolive during the second quarter worth about $44,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CL has been the subject of several recent analyst reports. UBS Group increased their price target on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a report on Wednesday, January 14th. JPMorgan Chase & Co. boosted their price objective on Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Citigroup increased their target price on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. Deutsche Bank Aktiengesellschaft raised their target price on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. Finally, Bank of America lifted their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. Eleven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $94.75.

Insider Buying and Selling

In other Colgate-Palmolive news, insider John Hazlin sold 20,989 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the transaction, the insider owned 17,645 shares of the company’s stock, valued at $1,663,041.25. The trade was a 54.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Stanley J. Sutula III sold 97,843 shares of the company’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the sale, the chief financial officer owned 55,310 shares in the company, valued at approximately $5,214,073.70. This represents a 63.89% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 184,683 shares of company stock worth $17,486,693 in the last three months. Insiders own 0.41% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE CL opened at $93.55 on Monday. The firm’s 50 day moving average is $88.98 and its 200-day moving average is $83.03. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. The company has a market capitalization of $75.41 billion, a PE ratio of 35.71, a price-to-earnings-growth ratio of 4.22 and a beta of 0.28. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.91 earnings per share. Equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were given a $0.52 dividend. The ex-dividend date of this dividend was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive’s payout ratio is currently 79.39%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.